Skip to content
Menu

Head-to-head comparison

Lumora vs REMEVi

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Ranked #379
Lumora

Lumora (Blue Skies MD LLC dba Lumora MD) is a physician-founded telehealth platform offering compounded semaglutide and tirzepatide in injectable and sublingual forms.

From $199/mo (lowest dose rung) sema · From $299/mo (lowest dose rung) tirz · Verified July 2026

Marked down on: Pricing is fully gated behind the assessment — no public pricing; actual monthly costs unverifiable without completing intake

vs
Ranked #23Desk pick
REMEVi

A flat $219 a month for semaglutide and $319 for tirzepatide at every dose, lower on 12- and 24-week plans, with four named pharmacies and the whole program in English or Spanish.

$219/mo sema · $319/mo tirz · Verified August 2026

Marked down on: The flat rate is a higher entry price than teaser-led competitors

REMEVi takes this head-to-head with the higher Desk Score, 86/100 (B) against 57/100 (C) for Lumora. Lumora still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Lumora

57/100

C

Overall

REMEVi

86/100

B

Price transparency

30
84

State access

24
96

Molecule range

83
82

Onboarding speed

76
82

Support responsiveness

83
82

Licensing & trust

84
88

The spec sheet

FieldLumoraREMEVi
SemaglutideFrom $199/molowest dose rung$199/mo (starting dose, plus a separate fee, compounded)$219/mo$219/mo month-to-month; $189/mo on a 12-week plan; $179/mo on a 24-week plan; same price at every dose; oral tablet $349/mo month-to-month or $309/mo on a 12-week plan
TirzepatideFrom $299/molowest dose rung$299/mo (starting dose, compounded)$319/mo$319/mo month-to-month; $249/mo on a 12-week plan; $229/mo on a 24-week plan; same price at every dose; compounded injectable
CoverageNot listed on Lumora's site (checked July 2026)All 50 states and DC
Brand-nameCompounded onlyCompounded only
Oral optionYesYes
Best forAdults wanting physician-led compounded GLP-1 care with labs, follow-up, and peptide options included.Someone who wants one price that never climbs with the dose — or a Spanish-speaking patient who wants the intake, portal and care team in their own language.
Desk Score57/100C86/100B

The verdict

Desk pick — REMEVi

REMEVi takes this head-to-head with the higher Desk Score, 86/100 (B) against 57/100 (C) for Lumora. Lumora still holds its ground where its strengths line up with yours.

Choose Lumora if…

Adults wanting physician-led compounded GLP-1 care with labs, follow-up, and peptide options included.

From $199/mo (lowest dose rung) sema · From $299/mo (lowest dose rung) tirz

Choose REMEVi if…

Someone who wants one price that never climbs with the dose — or a Spanish-speaking patient who wants the intake, portal and care team in their own language.

$219/mo sema · $319/mo tirz · All 50 states and DC

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Lumora · REMEVi.

Also here

CoreAge Rx leads the whole ranking at 94/100

Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.